Lanean...
Repurposing of Kinase Inhibitors as Broad-Spectrum Antiviral Drugs
The high cost of drug development and the narrow spectrum of coverage typically provided by direct-acting antivirals limit the scalability of this antiviral approach. This review summarizes progress and challenges in the repurposing of approved kinase inhibitors as host-targeted broad-spectrum antiv...
Gorde:
| Argitaratua izan da: | DNA Cell Biol |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Mary Ann Liebert, Inc.
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5804095/ https://ncbi.nlm.nih.gov/pubmed/29148875 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/dna.2017.4033 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|